Cytodyn Inc (CYDY)

[Rockleo]

Honestly the most significant fact about the CD12 study is..!!!
A
Day 28 Mortality (All SOC) Leronlimab 34/205(16.6%). Placebo 24/104(23%)
B
Day 28 Mortality (Dexamethasone) Leronlimab 25/155(16.1%) Placebo 17/78(21.8%)

Does Everybody see..That with All Standard of care including Dexamethasone the Mortality is 23%... Add Leronlimab and it comes down to 16.6%..

When Dexamethasone is Definitely used (B).. with or without other SOC( Remdesivir..Hcq etc) the mortality is still 21.8%... Add Leronlimab and it comes down to 16.1%...

How can you not give approval for Leronlimab..??

Huh..!!!